loadpatents
name:-0.015230894088745
name:-0.0067720413208008
name:-0.00056314468383789
Pizzocaro; Roberta Patent Filings

Pizzocaro; Roberta

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pizzocaro; Roberta.The latest application filed is for "process for preparing amorphous rifaxmin and the amorphous rifaximin thus obtained".

Company Profile
0.9.15
  • Pizzocaro; Roberta - Milan IT
  • Pizzocaro; Roberta - Milano IT
  • Pizzocaro; Roberta - Rodano MI
  • Pizzocaro; Roberta - Rodano N/A IT
  • Pizzocaro; Roberta - Garbagnate M. SE N/A IT
  • Pizzocaro; Roberta - Mulazzano IT
  • Pizzocaro; Roberta - Garbagnate IT
  • Pizzocaro; Roberta - Garbagnate Milanese IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Method for preparing a rifaximin product
Grant 9,273,063 - Vecchio , et al. March 1, 2
2016-03-01
Process For Preparing Amorphous Rifaxmin And The Amorphous Rifaximin Thus Obtained
App 20150011750 - Vecchio; Emilio ;   et al.
2015-01-08
Process For The Preparation Of Rotigotine
App 20130345283 - Banfi; Aldo ;   et al.
2013-12-26
Process For Preparing Amorphous Rifaxmin And The Amorphous Rifaximin Thus Obtained
App 20130338355 - VECCHIO; Emilio ;   et al.
2013-12-19
Process For The Preparation Of Rotigotine
App 20130317255 - Banfi; Aldo ;   et al.
2013-11-28
Process for the preparation of rotigotine
Grant 8,519,160 - Banfi , et al. August 27, 2
2013-08-27
Adefovir dipivoxil crystalline monohydrate form
Grant 8,389,722 - Galimi , et al. March 5, 2
2013-03-05
Crystalline irinotecan hydrochloride and methods for its preparation
Grant 8,247,426 - Pozzi , et al. August 21, 2
2012-08-21
Process For The Preparation Of Rotigotine
App 20110230541 - Banfi; Aldo ;   et al.
2011-09-22
Process for the preparation and purification of valgancyclovir hydrochloride
Grant 7,935,818 - Belogi , et al. May 3, 2
2011-05-03
Crystalline Irinotecan Hydrochloride And Methods For Its Preparation
App 20100179180 - POZZI; Giovanni ;   et al.
2010-07-15
Process for preparing amorphous rifaximin and the amorphous rifaximin thus obtained
App 20100137580 - Vecchio; Emilio ;   et al.
2010-06-03
Process For The Preparation Of Tigecycline In The Amorphous Form
App 20090275766 - POZZI; Giovanni ;   et al.
2009-11-05
Crystalline Polymorphs of Topotecan Hydrochloride and Methods for the Preparation Thereof
App 20090192184 - Pozzi; Giovanni ;   et al.
2009-07-30
Process for the preparation of 1-naphthol mixed ethers and intermediates of crystalline forms of (+) and (-)-duloxetine
Grant 7,553,978 - Frigoli , et al. June 30, 2
2009-06-30
Atomoxetine Hydrochloride Pure Crystalline Form
App 20090156863 - Malpezzi; Luciana ;   et al.
2009-06-18
Process For Preparation Of Pure Acitretin
App 20090118538 - PIZZOCARO; Roberta ;   et al.
2009-05-07
Process for the Preparation of 1-Naphthol Mixed Ethers and Intermediates of Crystalline Forms of (+) and (-)-Duloxetine
App 20080287693 - Frigoli; Samuele ;   et al.
2008-11-20
Process for the preparation and purification of valgancyclovir
App 20080076923 - Belogi; Gianluca ;   et al.
2008-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed